KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Cash from Financing Activities (2016 - 2025)

Elevance Health (ELV) has disclosed Cash from Financing Activities for 17 consecutive years, with $243.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Financing Activities rose 126.56% to $243.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$566.0 million, a 7.06% increase, with the full-year FY2024 number at $1.2 billion, up 135.62% from a year prior.
  • Cash from Financing Activities was $243.0 million for Q3 2025 at Elevance Health, up from -$308.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $3.4 billion in Q1 2021 to a low of -$1.9 billion in Q1 2025.
  • A 5-year average of -$264.5 million and a median of -$394.0 million in 2023 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: surged 457.36% in 2024, then plummeted 6065.62% in 2025.
  • Elevance Health's Cash from Financing Activities stood at -$1.3 billion in 2021, then surged by 80.38% to -$258.0 million in 2022, then plummeted by 52.71% to -$394.0 million in 2023, then soared by 457.36% to $1.4 billion in 2024, then crashed by 82.74% to $243.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Cash from Financing Activities are $243.0 million (Q3 2025), -$308.0 million (Q2 2025), and -$1.9 billion (Q1 2025).